Amar Parimi, MD
Family Medicine · Rancho Mirage, CANPI 1831266196
Payments from drug & device makers
Across 158 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$595
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$375
- Lilly USA, LLC$360
- AbbVie$288
- Amgen$270
- GSK$132
- plus $970 from 24 others
What the payments were for
- Food & beverage$2,991100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 42 | $595 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $375 |
| Lilly USA, LLC | 14 | $360 |
| AbbVie(2 entities) | 14 | $288 |
| Amgen | 12 | $270 |
| GSK | 6 | $132 |
| Johnson & Johnson | 6 | $113 |
| Amarin Pharma, Inc. | 5 | $95 |
| AstraZeneca | 5 | $92 |
| Pfizer | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Astellas Pharma US Inc | 2 | $52 |
| Boehringer Ingelheim | 2 | $47 |
| Biohaven Pharmaceuticals, Inc. | 2 | $46 |
| Exact Sciences | 2 | $45 |
| Merck | 2 | $33 |
| Dynavax Technologies Corporation | 3 | $25 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Medtronic | 1 | $24 |
| GRT US Holding, Inc. | 1 | $24 |
| Novartis | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Boston Scientific | 1 | $17 |
| Abbott | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
How this compares
$2,991 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $3,602 |
| Atorvastatin Calcium | 113 | $1,361 |
| Levothyroxine Sodium | 70 | $770 |
| Rosuvastatin Calcium | 23 | $732 |
| Amlodipine Besylate | 92 | $534 |
| Gabapentin | 49 | $467 |
| Lisinopril | 63 | $428 |
| Metoprolol Succinate | 25 | $385 |
| Metformin Hcl | 54 | $368 |
| Buspirone Hcl | 24 | $307 |
| Omeprazole | 31 | $301 |
| Losartan Potassium | 31 | $271 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $264 |
| Furosemide | 36 | $255 |
| Escitalopram Oxalate | 12 | $255 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Rancho Mirage
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.